Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Adenoma × defactinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 3 Neoplasms, Mesothelial 1 Mesothelioma 1 Carcinoma, Ovarian Epithelial 1 Adenoma 1

Interventions

Colonoscopy 2 Aspirin 2 defactinib 1 Sunitinib 1 Calcium Carbonate 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02004028 2024-02-20

Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants

Verastem, Inc.

Phase 2 Terminated

35 enrolled 15 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Adenoma, Mesothelioma, Neoplasms, Mesothelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡